购物车
0
有库存
HIT212670822
 sdf 文件
结构编辑
类似物检索
HIT212670822
  • HIT ID:HIT212670822
  • Cas No:2702297-24-1
  • 常用名:FGTI-2734 mesylate (1247018-19-4 free base)
    常用名:FGTI-2734 mesylate (1247018-19-4 free base)
  • 别名:FGTI-2734 mesylate
  • IUPAC:N-{2-[(4-cyano-2-fluorophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino]ethyl}-N-(cyclohexylmethyl)pyridine-2-sulfonamide; methanesulfonic acid
    IUPAC:N-{2-[(4-cyano-2-fluorophenyl)[(1-methyl-1H-imidazol-5-yl)methyl]amino]ethyl}-N-(cyclohexylmethyl)pyridine-2-sulfonamide; methanesulfonic acid
  • InChI key:CVSSKDKRVCBPOV-UHFFFAOYSA-N
  • 分子式:C27H35FN6O5S2
  • 分子量:606.73
  • 氢键供体数 (HBD):0
  • 氢键受体数 (HBA):6
  • LogP:4.17594
  • SMILES:CS(O)(=O)=O.Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(cc1F)C#N
    SMILES:CS(O)(=O)=O.Cn1cncc1CN(CCN(CC1CCCCC1)S(=O)(=O)c1ccccn1)c1ccc(cc1F)C#N
  • FGTI-2734 mesylate, a RAS C-terminal mimetic compound with dual farnesyl transferase (FT) and geranylgeranyl transferase-1 (GGT) inhibitory activities (IC50s of 250 nM and 520 nM for FT and GGT, respectively), mitigates KRAS resistance by preventing its membrane localization, effectively impeding mutant KRAS patient-derived pancreatic tumors.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    8-10周
    纯度
    -
    ¥ 14,900.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~